A lung transplant mostly remains the only choice for many patients having end-stage lung disease, a medical condition that can cause by pulmonary fibrosis, emphysema, other lung disorders, and cystic fibrosis. Nevertheless, the menace of organ failure and death following a lung transplant is very high, mainly correlated with the results of transplant patients who obtain new kidneys, hearts, or livers. Mostly, the reason is lung rejection, which happens when cells in the individual’s immune system recognize the donor lung as an unfamiliar threat. This circumstance generally is handled by giving patients prescriptions to hold back the immune system.
Nevertheless, one major deadly form of dismissal—known as antibody-mediated rejection—is difficult to identify following a lung transplant and is usually impervious to accessible treatments. This procedure has been scrutinized in over 10% of lung transplant receivers. It happens when a kind of WBC (white blood cell) from the recipient creates antibodies alongside the donor’s lung. Currently, a study conducted by scientists at WUSM (Washington University School of Medicine), St. Louis, has found a process in mice that might avert antibody-mediated dismissal and guide to the development of therapies to cure this form of elimination. The study was published in the Journal of Clinical Investigation.
Lately, the WUSM was in news for stating brains of women appear 3 Years younger than men’s. Time impacts differently on men’s and women’s brains. While the brain is likely to shrink with age, men’s brain reduces faster than women’s. The metabolism of brain slows as people grow elder and this too, might differ amid women and men. The research stated that women’s brains seem to be about 3 Years younger than men’s brain of the same sequential age, considering metabolically. The results were published in the PNAS (Proceedings of the National Academy of Sciences). This can be one of the evidence why women are prone to stay mentally active longer than men.